Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe, +2329

Autophagy

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

Noëlia Casares, Marie O. Péquignot, Antoine Tesnière, +15

The Journal of Experimental Medicine

ImmunologyImmunoeditingCell DeathImmunotherapyTumor Biology +14

Salinomycin kills cancer stem cells by sequestering iron in lysosomes

Trang Thi, Ahmed Hamaï, Antje Hienzsch, +14

Nature Chemistry

Malignant DiseaseMedicineStem Cell ToxicologyStem Cell ResearchCancer Biology +8

Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression

Gehao Liang, Yun Ling, Maryam Mehrpour, +15

Molecular Cancer

Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance

Wen Yue, Ahmed Hamaï, Giovanni Tonelli, +5

Autophagy

MitophagyBreast OncologyAutophagic FluxBreast Cancer TissueCell Proliferation +16

Autophagy modulates cell migration and β1 integrin membrane recycling

Véronique Tuloup-Minguez, Ahmed Hamaï, Anne Greffard, +3

Cell Cycle

Reactive Oxygen Species, AMP-activated Protein Kinase, and the Transcription Cofactor p300 Regulate α-Tubulin Acetyltransferase-1 (αTAT-1/MEC-17)-dependent Microtubule Hyperacetylation during Cell Stress

Rafah Mackeh, Séverine Lorin, Ameetha Ratier, +7

Journal of Biological Chemistry

Molecular RegulationCytoskeletonReactive Oxygen SpeciesCellular PhysiologyTranscriptional Regulation +15

circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer

Yun Ling, Gehao Liang, Qun Lin, +15

Molecular Cancer

ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway

Ahmed Hamaï, Franck Meslin, Houssem Benlalam, +8

Cancer Research

Ctl CloneCancer ImmunosurveillanceDifferential SusceptibilityMelanomaImmunology +11

GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functions

Sonia Brun, Eloïne Bestion, Éric Raymond, +22

Autophagy